[Federal Register Volume 88, Number 248 (Thursday, December 28, 2023)]
[Notices]
[Pages 89696-89697]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-28616]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--CE22-003, Rigorously Evaluating Programs and 
Policies To Prevent Child Sexual Abuse (CSA); Amended Notice of Closed 
Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)--CE22-003, Rigorously Evaluating Programs and Policies to Prevent 
Child Sexual Abuse (CSA); April 11, 2024, 8:30 a.m.-5 p.m., EDT, 
videoconference, in the original Federal Register notice. The meeting 
notice was published in the Federal Register on November 2, 2023, 
Volume 88, Number 211, page 75287.
    The notice is being amended to change the start time to 10:30 a.m. 
The notice should read as follows:
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)--CE22-003, Rigorously Evaluating 
Programs and Policies to Prevent Child Sexual Abuse (CSA).
    Date: April 11, 2024.
    Time: 10:30 a.m.-5 p.m., EDT.
    The meeting is closed to the public.

FOR FURTHER INFORMATION CONTACT: Aisha L. Wilkes, M.P.H., Scientific 
Review Officer, National Center for Injury Prevention and Control, 
Centers for Disease Control and Prevention, 4770 Buford Highway NE, 
Mailstop S106-9, Atlanta, Georgia 30341.

[[Page 89697]]

Telephone: (404) 639-6473; Email: [email protected].
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-28616 Filed 12-27-23; 8:45 am]
BILLING CODE 4163-18-P